[
  {
    "ts": null,
    "headline": "Cathie Wood Goes Shopping: 3 Stocks She Just Bought",
    "summary": "Ark Invest bought into some of its leaders and laggards on Monday.",
    "url": "https://finnhub.io/api/news?id=e8f610e70eff482ad16c5a8b1462cbf4b81de9a0fc103c84e86f5e6361aa80d7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753794900,
      "headline": "Cathie Wood Goes Shopping: 3 Stocks She Just Bought",
      "id": 136118977,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Ark Invest bought into some of its leaders and laggards on Monday.",
      "url": "https://finnhub.io/api/news?id=e8f610e70eff482ad16c5a8b1462cbf4b81de9a0fc103c84e86f5e6361aa80d7"
    }
  },
  {
    "ts": null,
    "headline": "5 Must-Read Analyst Questions From Intuitive Surgical’s Q2 Earnings Call",
    "summary": "Intuitive Surgical’s second quarter results were marked by strong procedure growth and robust capital equipment placements, which together helped the company exceed Wall Street’s top- and bottom-line expectations. Management attributed the quarter’s momentum to continued adoption of the da Vinci 5 robotic surgical system, particularly in the United States, as well as solid execution in expanding its installed base across key international markets. CEO Dave Rosa highlighted that “benign general s",
    "url": "https://finnhub.io/api/news?id=18c476108b09cafb348580164f9a68cba070d99cdcaaa4fc02ef0c5022a3e137",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753767231,
      "headline": "5 Must-Read Analyst Questions From Intuitive Surgical’s Q2 Earnings Call",
      "id": 136129921,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Intuitive Surgical’s second quarter results were marked by strong procedure growth and robust capital equipment placements, which together helped the company exceed Wall Street’s top- and bottom-line expectations. Management attributed the quarter’s momentum to continued adoption of the da Vinci 5 robotic surgical system, particularly in the United States, as well as solid execution in expanding its installed base across key international markets. CEO Dave Rosa highlighted that “benign general s",
      "url": "https://finnhub.io/api/news?id=18c476108b09cafb348580164f9a68cba070d99cdcaaa4fc02ef0c5022a3e137"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer on Intuitive Surgical: “I’m Inclined to Recommend the Stock”",
    "summary": "Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the stocks that Jim Cramer weighed in on. In response to a caller’s query about the company, Cramer commented: “You and I are in the exact same place. They were talking about the second quarter placement not being that good. I didn’t see it that way… I think […]",
    "url": "https://finnhub.io/api/news?id=996343c8170d4ab5137d668c79bb7df391ab2ec20b8aa9cddc6d5c4c0ca7f373",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753766929,
      "headline": "Jim Cramer on Intuitive Surgical: “I’m Inclined to Recommend the Stock”",
      "id": 136113469,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the stocks that Jim Cramer weighed in on. In response to a caller’s query about the company, Cramer commented: “You and I are in the exact same place. They were talking about the second quarter placement not being that good. I didn’t see it that way… I think […]",
      "url": "https://finnhub.io/api/news?id=996343c8170d4ab5137d668c79bb7df391ab2ec20b8aa9cddc6d5c4c0ca7f373"
    }
  },
  {
    "ts": null,
    "headline": "BME: The Resilient Income Investment Of The Healthcare Industry",
    "summary": "BlackRock Health Sciences Trust offers a resilient 8.63% dividend yield, low expense ratio, and conservative, low-risk positioning. See more on BME ETF here.",
    "url": "https://finnhub.io/api/news?id=78240d01203e7108640de3e61a12e015ad3c84d30c01e10965bf01bcf0b6bbe0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753747321,
      "headline": "BME: The Resilient Income Investment Of The Healthcare Industry",
      "id": 136112843,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1635084121/image_1635084121.jpg?io=getty-c-w1536",
      "related": "ISRG",
      "source": "SeekingAlpha",
      "summary": "BlackRock Health Sciences Trust offers a resilient 8.63% dividend yield, low expense ratio, and conservative, low-risk positioning. See more on BME ETF here.",
      "url": "https://finnhub.io/api/news?id=78240d01203e7108640de3e61a12e015ad3c84d30c01e10965bf01bcf0b6bbe0"
    }
  }
]